The rising tide of dementia worldwide  by Larson, Eric B & Langa, Kenneth M
Comment
430 www.thelancet.com   Vol 372   August 9, 2008
in the general population, it is diﬃ  cult to exclude chance 
as an explanation for their ﬁ ndings.
In today’s study, Vestergaard and colleagues tested 
the hypothesis that febrile seizures are associated with 
an increased risk of death, by examining mortality 
data from a cohort of more than 1·6 million children, 
including over 55 000 children with febrile seizures and 
over 8000 deaths. They noted that in children who had a 
febrile seizure, there was an increased risk of death in the 
2 years after the ﬁ rst febrile seizure, but that the absolute 
risk of death was still very low. In a nested case-control 
study, they attempted to ﬁ nd more clinical information 
than is usually available in registry data, through review 
of medical records. They report that the increased risk of 
death after febrile seizure was seen only in children with 
complex febrile seizures and in those with underlying 
neurological abnormalities.
Vestergaard and colleagues’ study again seems to 
refute, for infants and children who have simple febrile 
seizures, the idea of a shared cause between febrile 
seizures and sudden death. Similar to previous studies, 
most recently that of Kinney and colleagues, the new 
study suggests there is a subset of children with febrile 
seizures—notably those with complex features and 
underlying neurological abnormalities—that might 
warrant closer attention and follow-up.
Our grasp of the personal and public-health challenges 
that dementia poses worldwide keeps evolving. A major 
step is reported in today’s Lancet by Juan Llibre Rodriguez 
and colleagues from the 10/66 Dementia Research 
Group in a population-based study.1
Less than 40 years ago, Alzheimer’s disease was 
lumped with Pick’s disease as a presenile dementia; 
and cognitive decline, including extreme senility, was 
supposedly part of a continuum of normal ageing. That 
view became untenable when the numbers of elderly 
people in developed countries mush roomed. Dementias 
occur mainly in old people, doubling in prevalence 
about every 5 years after 65 years of age in developed 
countries2 and every 7 years in devel oping ones.
More recently, dementia research has posited mild 
cognitive impairment, a curious and heterogeneous 
condition. Some call it a disease, but others say that 
makes it into a process that can be part of normal 
ageing. Mild cognitive impairment is common in elderly 
people and aﬀ ects nearly one in four older than 70 years 
of age.3 The condition does not neces sar ily lead to 
dementia. By itself, it characteristically causes no sub-
stantial dysfunction, other than sub jective worry.
Llibre Rodriguez and colleagues studied rates of 
dementia in elderly people in low-income and middle-
income countries. They found that the rates of dementia 
varied widely between nations but tended to be higher 
than previously thought; and rates in urban Latin America 
(approaching 10%) resemble those in high-income 
countries. Populations world wide are increasingly 
ageing, so late-life dementias have far-reaching con-
sequences for health.
Dementia is rare in people younger than 65 years of 
age, but incidence increases exponentially with age, 
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especially when older than 80 years.4 Interestingly, the 
eﬀ ect of dementia on survival is not uniform. The earlier 
its onset, the more Alzheimer’s disease causes excess 
mortality. Diﬀ erences in survival between aﬀ ected and 
unaﬀ ected populations decrease progressively with 
age. In one study, for individuals in Seattle with onset 
after age 90 years, survival diﬀ erences were minor.5 
More over, dementia is not an inevitable consequence 
of old age as shown by a well-described Belgian woman 
who survived until aged 115 years with good cognitive 
function, no preclinical indications of Alzheimer’s disease, 
and almost no neuro degenerative changes on examin-
ation of the brain.6
The rising tide of late-life dementia is both a triumph 
of public health and an opportunity. Increased worldwide 
prevalence reﬂ ects gains in life expectancy, perhaps 
made more evident in present knowledge-based 
societies.7 Cognitive skills are probably more essen tial 
for survival—and sustain wellbeing better—in cities, 
where people are increasingly concentrated. Because 
the rates rise considerably in late old age, delaying the 
onset of functional impairment would represent true 
prevention—or at least compression of morbidity.8
Data from the population-based Health and Retirement 
Study suggest that rates of cognitive impairment are 
decreasing in the USA,9 from 12·2% in those older than 
70 years in 1993 to 8·7% in 2002. The interval between 
onset of substantial cogni tive decline and death seems 
to have decreased too, suggesting a compression of 
cognitive morbidity. The change in rates was mainly 
associated with higher education and wealth, and 
probably with improved control of cardiovascular risk.
Progress made to achieve higher levels of education 
worldwide and better general health and control of 
cardiovascular risk factors could help postpone dis-
ease processes, delaying dementia as lifespan becomes 
increasingly genetically determined; as environ mental 
factors are recognised and controlled, genetic factors 
become more important. Education of successive 
generations might multiply the delay of dementia.10 
Education of women might help protect their children 
from developing late-life dementia.11
Llibre Rodriguez and colleagues suggest that in many 
cultures, with high degrees of support and respect for 
older people, relatives might not perceive dementia as a 
problem. Similarly, one could debate the merits of turning 
mild cognitive impairment into a disease. The current 
focus on eﬀ orts to better understand mild cognitive 
impairment will probably have less value than many hope 
for the public’s health. Secondary prevention trials in 
individuals with mild cognitive impairment designed to 
test whether dementia can be delayed are an appropriate 
area for research. However, the risk of late-life cognitive 
decline and processes causing dementia probably orig-
inates throughout an individual’s lifespan.
Similarly to the degenerative coronary artery disease 
in young US soldiers who died in the Korean conﬂ ict 
in the 1950s,12 neuropathological changes and subtle 
diﬀ erences in cognition occur early in life, well before 
clinical disease manifests. So eﬀ orts that promote general 
health (improved education and nutrition, control 
of cardiovascular risk, and physical and cognitively 
engaging activities) could delay progression of the 
degenerative changes of Alzheimer’s disease in the brain 
and vascular diseases.13 Growing evidence also supports 
brain plasticity,14 contradicting the long-held notion that 
damaged brain tissue cannot regenerate or be restored. 
Brain plasticity implies that opportunities exist to modify 
changes in the brain related to age and even to disease.
The 10/66 study will provide unique opportunities 
to explore environmental eﬀ ects on the ageing process 
in the brain. Llibre Rodriguez and colleagues rightly 
emphasise the formidable challenges of measuring 
cognition and its eﬀ ects on function across cultures. 
We applaud their focus on actual function and especially 
functional impairment, which leads to suﬀ ering and 
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dependency. We should work towards letting more of 
the world’s people experience long life as a reward for 
their many years of life—not as punishment for the 
triumphs of modern medicine and public health.
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The Wakley Prize 2008
Thomas Wakley, who founded The Lancet in 1823 when 
he was only 28 years old, was a swashbuckling larger-
than-life character. The annual Wakley Prize is named 
in his honour and seeks to exemplify the spirit of a 
man who was passionately committed to reforming 
the practice of medicine and to improving the lives of 
patients. The prize is given to the best essay on a topic 
of international health importance. Last year’s winner, 
in telling the story of a Cree man living with diabetes in 
an Aboriginal village in northern Saskatchewan, Canada, 
illuminated how medicine and culture can sometimes 
ﬁ nd themselves at odds, and how, or whether, those 
diﬀ erences can be reconciled.1 In a larger sense, the 
essay was about the diﬃ  culty of truly knowing another.
We are looking for fresh new writing that critically 
examines these and other challenges in contemporary 
medicine. Essays must be submitted before Oct 31, 
2008, and may not exceed 2000 words. The winner will 
be determined by Lancet editors (who will judge each 
entry without knowing the author’s identity), and will 
receive £2000 and publication in the ﬁ nal issue of the 
year. The contest is open to anyone working or training 
in a health-related ﬁ eld. Essays must be submitted 
through The Lancet’s electronic submission system, with 
Wakley Prize essay speciﬁ ed as the article type.
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To submit an essay go to 
http://ees.elsevier.com/
thelancet/default.asp 
